Drug hypersensitivity syndrome associated with a primary HHV6 infection;Syndrome d'hypersensibilité médicamenteuse associé à une primo-infection HHV6

Annales de Dermatologie et de Venereologie

Volumn 133, Issue 2, 2006, Pages 145-147

  Debarbieux, S ^a   Deroo Berger, M C ^a   Grande, S ^a   Najioullah, F ^b   Kanitakis, J ^a   Faure, M ^a   Claudy, A ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISONE; PREDNISONE ACETATE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DRUG HYPERSENSITIVITY; DRUG HYPERSENSITIVITY SYNDROME; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; LIVER FAILURE; RHEUMATIC DISEASE; SKIN MANIFESTATION; TREATMENT OUTCOME; DRUG ERUPTION; MIDDLE AGED; SYNDROME; TIME; TOXIC HEPATITIS; VIRUS INFECTION;

ADRENAL CORTEX HORMONES; ANTIRHEUMATIC AGENTS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HEPATITIS, TOXIC; HERPESVIRUS 6, HUMAN; HUMANS; MIDDLE AGED; ROSEOLOVIRUS INFECTIONS; SULFASALAZINE; SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 33645979663     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(06)70865-1     Document Type: Article

References (26)

1. Begon E, Roujeau JC. Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Ann Dermatol Venereol 2004;131:293-7.
2. Callot V, Roujeau JC, Bagot M, Wechsler J, Chosidow O, Souteyrand P, et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol 1996;132:1315-21.
3. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001;137:357-64.
4. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998;134:1108-12.
5. Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998;134:113-7.
6. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997;137:605-8.
7. Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137:301-4.
8. Descamps V, Collot S, Mahe E, Houhou N, Crickx B, Ranger-Rogez S. Active human herpesvirus 6 infection in a patient with drug rash with eosinophilia and systemic symptoms. J Invest Dermatol 2003;121:215-6.
9. Descamps V, Collot S, Houhou N, Ranger-Rogez S. Human herpesvirus-6 encephalitis associated with hypersensitivity syndrome. Ann Neurol 2003;53:280.
10. Mahe E, Bodemer C, Dupic L, Hubert P, Lacaille F, Goulet O, et al. Drug-induced hypersensitivity syndrome associated with primary Epstein-Barr virus and human herpesvirus 6 infections in a child intestinal transplant recipient. Transplantation 2004;77:479-80.
11. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986;105:179-84.
12. Okuno T, Takahashi K, Balachandra K, Shiraki K, Yamanishi K, Takahashi M, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989;27:651-3.
13. Akashi K, Eizuru Y, Sumiyoshi Y, Minematsu T, Hara S, Harada M, et al. Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 1993;329:168-71.
14. Niederman JC, Liu CR, Kaplan MH, Brown NA. Clinical and serological features of human herpesvirus-6 infection in three adults. Lancet 1988;2:817-19.
15. Sobue R, Miyazaki H, Okamoto M, Hirano M, Yoshikawa T, Suga S, et al. Fulminant hepatitis in primary human herpesvirus-6 infection. N Engl J Med 1991;324:1290.
16. Ishikawa K, Hasegawa K, Naritomi T, Kanai N, Ogawa M, Kato Y, et al. Prevalence of herpesviridae and hepatitis virus sequences in the livers of patients with fulminant hepatitis of unknown etiology in Japan. J Gastroenterol 2002;37:523-30.
17. Harma M, Hockerstedt K, Lautenschlager I. Human herpesvirus-6 and acute liver failure. Transplantation 2003;76:536-9.
18. Carrigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK, Ash RC. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 1991;338:147-9.
19. Knox KK, Carrigan DR. Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9 :69-73.
20. Fujino Y, Nakajima M, Inoue H, Kusuhara T, Yamada T. Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome. Ann Neurol 2002;51:771-4.
21. Le Cleach L, Fillet AM, Agut H, Chosidow O. Human herpesviruses 6 and 7. New roles yet to be discovered? Arch Dermatol 1998;134:1155-7.
22. Frenkel N, Schirmer EC, Katsafanas G, June CH. T-cell activation is required for efficient replication of human herpesvirus 6. J Virol 1990;64:4598-602.
23. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995;155:462-72.
24. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004;140:183-8.
25. Wong GA, Shear NH. Is a drug alone sufficient to cause the drug hypersensitivity syndrome? Arch Dermatol 2004;140:226-30.
26. Bénéton N, Challine D, Delfau MH, Roujeau JC. Recherche du virus HHV6 dans les syndromes d'hypersensibilité médicamenteuse ou DRESS : étude de 17 cas. Ann Dermatol Venereol 1999;126:2S22-77.